Previous close | 13.30 |
Open | 13.15 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 15.00 |
Expiry date | 2024-06-21 |
Day's range | 13.15 - 13.40 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Insightful Analysis of Pfizer Inc's Financial Health and Strategic Position
(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion biotech giant and a public health hero. Its second vaccine, meant to prevent a common respiratory virus, is calling into question the premise on which the company has staked its entire business. Most Read from BloombergMicrosoft’s Xbox Is Planning More Cuts After Studio ClosingsAmericans Are Racking Up ‘Phantom Debt’ That Wall Street Can’t Track‘Seriously Underwater’ Home Mortgages Tick Up Across th
Pfizer stock ran up to its 50-day line after the company reported better-than-expected sales and profit. Is PFE stock a buy?